Product nameAnti-XAB2 antibody
See all XAB2 primary antibodies
DescriptionRabbit polyclonal to XAB2
Tested applicationsSuitable for: ICC/IF, WB, IPmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat, Rabbit, Guinea pig, Cow, Dog, Pig, Rhesus monkey, Chinese hamster, Orangutan
Synthetic peptide, corresponding to a region within amino acids 805-855 of Human XAB2 (NP_064581.2).
- HeLa, 293T and Jurkat whole cell lysate (ab7899)
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
Storage bufferPreservative: 0.09% Sodium azide
Constituent: 99% Tris citrate/phosphate
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab129487 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||Use at an assay dependent concentration.|
|WB||1/2000 - 1/10000. Predicted molecular weight: 100 kDa.|
|IP||Use at 2-10 µg/mg of lysate.|
FunctionInvolved in transcription-coupled repair (TCR), transcription and pre-mRNA splicing.
Sequence similaritiesBelongs to the crooked-neck family.
Contains 14 HAT repeats.
Cellular localizationNucleus. Detected in the splicing complex carrying pre-mRNA.
- Information by UniProt
- 0610041O14Rik antibody
- adapter protein ATH 55 antibody
- Adapter protein ATH-55 antibody
All lanes : Anti-XAB2 antibody (ab129487) at 0.04 µg/ml
Lane 1 : HeLa whole cell lysate at 50 µg
Lane 2 : HeLa whole cell lysate at 15 µg
Lane 3 : 293T whole cell lysate at 50 µg
Lane 4 : Jurkat whole cell lysate at 50 µg
Developed using the ECL technique.
Predicted band size: 100 kDa
Exposure time: 30 seconds
Lane 1: ab129487 at 0.4 µg/ml staining XAB2 in HeLa whole cell lysate immunoprecipitated using ab129487 at 6 µg/mg lysate (1 mg/IP; 20% of IP loaded/lane).
Lane 2: control IgG.
Exposure time: 3 seconds
ab129487 has not yet been referenced specifically in any publications.